A Study of HDM2024 in Participants With Advanced Solid Tumors

Clinical trial NCT07539285 · RECRUITING

Trial details

NCT number: NCT07539285
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2026-04-10
Primary completion: 2027-04-15
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.